PPARA and primary biliary cholangitis: In addition, several recent clinical studies (Jones et al., 2017; Schattenberg et al., 2021; Vuppalanchi et al., 2022) have reported the results of Phase 2 clinical trials of PPAR agonists for the treatment of PBC, highlighting their potential as novel therapeutics for PBC.